[Skip to Navigation]
Sign In

November 2022 - July 1883

Decade

Year

Issue

April 28, 2020, Vol 323, No. 16, Pages 1529-1626

In This Issue of JAMA

Audio Highlights

Abstract Full Text
free access online only has audio
JAMA. 2020;323(16):e200018. doi:10.1001/jama.2020.0018
Original Investigation

Effect of Apabetalone Added to Standard Therapy on Major Adverse Cardiovascular Events in Patients With Recent Acute Coronary Syndrome and Type 2 Diabetes: A Randomized Clinical Trial

Abstract Full Text
free access has active quiz
JAMA. 2020;323(16):1565-1573. doi:10.1001/jama.2020.3308

This randomized trial compares the effects of apabetalone (an inhibitor of bromodomain 2 and extraterminal protein, 2 epigenetic “readers”) vs placebo on major adverse cardiovascular events in patients with acute coronary syndrome (ACS), type 2 diabetes, and low HDL cholesterol level.

Baseline Characteristics and Outcomes of 1591 Patients Infected With SARS-CoV-2 Admitted to ICUs of the Lombardy Region, Italy

Abstract Full Text
free access has active quiz has multimedia
JAMA. 2020;323(16):1574-1581. doi:10.1001/jama.2020.5394

This case series describes the demographics, comorbidities, ventilation requirements, dispositions, and mortality of patients with PCR-confirmed SARS-CoV-2 infection admitted to northern Italy ICUs in February-March 2020..

Preliminary Communication

Treatment of 5 Critically Ill Patients With COVID-19 With Convalescent Plasma

Abstract Full Text
free access has active quiz has multimedia has audio
JAMA. 2020;323(16):1582-1589. doi:10.1001/jama.2020.4783

This case series describes clinical outcomes in 5 Chinese patients with laboratory-confirmed COVID-19, ARDS, and high viral loads despite antiviral treatment who were given human plasma with SARS-CoV-2 antibodies obtained from previously infected and recovered patients.

Research Letter

Air, Surface Environmental, and Personal Protective Equipment Contamination by Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) From a Symptomatic Patient

Abstract Full Text
free access has active quiz has audio
JAMA. 2020;323(16):1610-1612. doi:10.1001/jama.2020.3227

This study documents results of SARS-CoV-2 polymerase chain reaction (PCR) testing of environmental surfaces and personal protective equipment surrounding 3 COVID-19 patients in isolation rooms in a Singapore hospital.

Characteristics and Outcomes of 21 Critically Ill Patients With COVID-19 in Washington State

Abstract Full Text
free access has audio
JAMA. 2020;323(16):1612-1614. doi:10.1001/jama.2020.4326

This case series describes the clinical presentation, characteristics, and outcomes of patients with coronavirus disease 2019 (COVID-19) admitted to the intensive care unit at a public hospital in Washington State in February 2020, including initial reports of cardiomyopathy in one-third of the patients.

Quality Measure Development and Associated Spending by the Centers for Medicare & Medicaid Services

Abstract Full Text
free access
JAMA. 2020;323(16):1614-1616. doi:10.1001/jama.2020.1816

This study uses data from the publicly available Centers for Medicare & Medicaid Services (CMS) Inventory Tool to determine the proportion of CMS quality measures that are used or finalized for use in a CMS program, under development or consideration for use, or not in use.

US Preventive Services Task Force

Recommendation Statement

Primary Care Interventions for Prevention and Cessation of Tobacco Use in Children and Adolescents: US Preventive Services Task Force Recommendation Statement

Abstract Full Text
free access has active quiz has audio
JAMA. 2020;323(16):1590-1598. doi:10.1001/jama.2020.4679

This 2020 Recommendation Statement from the US Preventive Services Task Force recommends that primary care clinicians provide interventions, including education or brief counseling, to prevent initiation of tobacco use among school-aged children and adolescents (B recommendation) and concludes that current evidence is insufficient to assess the benefits and harms of primary care interventions for cessation of tobacco use among school-aged children and adolescents (I statement).

Evidence Report

Primary Care–Relevant Interventions for Tobacco and Nicotine Use Prevention and Cessation in Children and Adolescents: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force

Abstract Full Text
free access has audio
JAMA. 2020;323(16):1599-1608. doi:10.1001/jama.2020.3332

This systematic review to support the 2020 US Preventive Services Task Force Recommendation Statement on interventions for prevention and cessation of tobacco and nicotine use summarizes published evidence on the benefits and harms of primary care–relevant interventions for tobacco and nicotine use prevention and cessation in children and adolescents.

Viewpoint

Critical Care Utilization for the COVID-19 Outbreak in Lombardy, Italy: Early Experience and Forecast During an Emergency Response

Abstract Full Text
free access has active quiz has multimedia has audio
JAMA. 2020;323(16):1545-1546. doi:10.1001/jama.2020.4031

This Viewpoint describes the organization of a regional ICU network in Lombardy, Italy, to handle the surge in patients infected with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) who require intensive care and uses demand experience in the first 2 weeks of the outbreak to estimate resources required in coming weeks.

Presidential Powers and Response to COVID-19

Abstract Full Text
free access
JAMA. 2020;323(16):1547-1548. doi:10.1001/jama.2020.4335

This Viewpoint reviews legal powers the US president and state governors have to implement travel and other restrictions to control the spread of coronavirus, and discusses the need to balance rights to privacy and liberty with public health in ways that do not disadvantage already vulnerable populations.

Managing COVID-19 in Low- and Middle-Income Countries

Abstract Full Text
free access has active quiz
JAMA. 2020;323(16):1549-1550. doi:10.1001/jama.2020.4169

This Viewpoint discusses challenges to managing a COVID-19 outbreak in low- and middle-income countries (LMICs), reviewing how absence of testing, critical care capacity, climate, war, distrust, and large refugee populations could complicate implementation of proven infection prevention and control measures.

The Role of Physicians in Addressing Social Determinants of Health

Abstract Full Text
has audio
JAMA. 2020;323(16):1551-1552. doi:10.1001/jama.2020.1637

This Viewpoint acknowledges that physicians in clinical roles may be limited in their ability to influence social determinants of patients’ health but proposes they have a role to play in educating others of its importance through teaching and training, diverse student and workforce recruitment, and activism.  

Addressing Social Determinants of Health: Time for a Polysocial Risk Score

Abstract Full Text
JAMA. 2020;323(16):1553-1554. doi:10.1001/jama.2020.2436

This Viewpoint introduces the notion of a polysocial risk score, much like a polygenic risk score, which might help predict the risk that varying combinations of social conditions contribute to specific health outcomes.

A Piece of My Mind

Personal Risk and Societal Obligation Amidst COVID-19

Abstract Full Text
free access has active quiz
JAMA. 2020;323(16):1555-1556. doi:10.1001/jama.2020.5450

In this narrative medicine essay, a resident physician with asthma describes her internal deliberations about public vs private good after a decision to retreat from direct-patient care to telemedicine to protect her health during the coronavirus pandemic.

Editorial

Epigenetic Therapeutics for Cardiovascular Disease: Writing, Erasing, Reading, and Maybe Forgetting

Abstract Full Text
JAMA. 2020;323(16):1557-1558. doi:10.1001/jama.2020.3298

Critical Illness in Patients With COVID-19: Mounting an Effective Clinical and Research Response

Abstract Full Text
free access has active quiz
JAMA. 2020;323(16):1559-1560. doi:10.1001/jama.2020.5775

Convalescent Plasma to Treat COVID-19: Possibilities and Challenges

Abstract Full Text
free access has active quiz
JAMA. 2020;323(16):1561-1562. doi:10.1001/jama.2020.4940

Recommendations From the USPSTF for Prevention and Cessation of Tobacco Use in Children and Adolescents

Abstract Full Text
has audio
JAMA. 2020;323(16):1563-1564. doi:10.1001/jama.2019.22312
Medical News & Perspectives

With First CRISPR Trials, Gene Editing Moves Toward the Clinic

Abstract Full Text
has multimedia has audio
JAMA. 2020;323(16):1537-1539. doi:10.1001/jama.2020.3438

This Medical News article discusses the first human genome editing studies using CRISPR-Cas9.

Quick Uptakes

Coconut Oil’s Health Halo a Mirage, Clinical Trials Suggest

Abstract Full Text
JAMA. 2020;323(16):1540-1541. doi:10.1001/jama.2020.5186

This Medical News article discusses a recent review of 17 clinical trials comparing the effects of coconut oil and other vegetable oils on cardiovascular disease risk factors.

News From the Centers for Disease Control and Prevention

Head Injury Deaths on the Rise

Abstract Full Text
JAMA. 2020;323(16):1544. doi:10.1001/jama.2020.5343

New York Hospital Was Likely Source of Young Man’s HIV Infection

Abstract Full Text
JAMA. 2020;323(16):1544. doi:10.1001/jama.2020.4240
Clinical Trials Update

Long-Acting Injectable HIV Therapy Noninferior to Daily Pills

Abstract Full Text
JAMA. 2020;323(16):1543. doi:10.1001/jama.2020.2815

Methotrexate and Adverse Events in CIRT Secondary Analysis

Abstract Full Text
JAMA. 2020;323(16):1543. doi:10.1001/jama.2020.5628

Limiting Vulnerable Infants’ Secondhand Smoke Exposure

Abstract Full Text
JAMA. 2020;323(16):1543. doi:10.1001/jama.2020.5629

Palliative Care Benefits Patients With Parkinson Disease

Abstract Full Text
JAMA. 2020;323(16):1543. doi:10.1001/jama.2020.5630

Alteplase Inhibits Nerinetide, a Novel Stroke Drug

Abstract Full Text
JAMA. 2020;323(16):1543. doi:10.1001/jama.2020.5631
Health Agencies Update

Using 2 Prostate Biopsy Techniques Optimizes Cancer Diagnosis

Abstract Full Text
JAMA. 2020;323(16):1542. doi:10.1001/jama.2020.4566

New AHRQ Patient Safety Guidance

Abstract Full Text
JAMA. 2020;323(16):1542. doi:10.1001/jama.2020.5603

Lower Out-of-Pocket Insulin Costs for Medicare Plan D Beneficiaries

Abstract Full Text
JAMA. 2020;323(16):1542. doi:10.1001/jama.2020.5604
Poetry and Medicine

Thangkhali Hospital at Night II

Abstract Full Text
JAMA. 2020;323(16):1620. doi:10.1001/jama.2020.0573
JAMA Revisited

The Influenza Outbreak

Abstract Full Text
JAMA. 2020;323(16):1621. doi:10.1001/jama.2020.6097
JAMA Patient Page

Preventing Tobacco Use in Children and Adolescents

Abstract Full Text
free access has audio
JAMA. 2020;323(16):1626. doi:10.1001/jama.2020.5349

This JAMA Patient Page describes the US Preventive Services Task Force’s recent recommendations for prevention and cessation of tobacco use in children and adolescents.

Comment & Response

Premature Menopause and Risk for Cardiovascular Disease

Abstract Full Text
JAMA. 2020;323(16):1616. doi:10.1001/jama.2020.2533

Premature Menopause and Risk for Cardiovascular Disease

Abstract Full Text
JAMA. 2020;323(16):1616-1617. doi:10.1001/jama.2020.2530

Premature Menopause and Risk for Cardiovascular Disease—Reply

Abstract Full Text
JAMA. 2020;323(16):1617-1618. doi:10.1001/jama.2020.2536

Health Outcomes With Vitamin D Supplementation

Abstract Full Text
JAMA. 2020;323(16):1618-1619. doi:10.1001/jama.2020.2642

Health Outcomes With Vitamin D Supplementation—Reply

Abstract Full Text
JAMA. 2020;323(16):1619. doi:10.1001/jama.2020.2645
Correction

Typographical Error

Abstract Full Text
free access
JAMA. 2020;323(16):1619. doi:10.1001/jama.2020.5249

Data Error in Viewpoint on COVID-19 in Italy

Abstract Full Text
free access
JAMA. 2020;323(16):1619. doi:10.1001/jama.2020.6122
JAMA Masthead

JAMA

Abstract Full Text
free access
JAMA. 2020;323(16):1529-1530. doi:10.1001/jama.2019.13404
×